Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Somersalo, K.
Right arrow Articles by Timonen, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Somersalo, K.
Right arrow Articles by Timonen, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 270, Number 15, Issue of April 14, pp. 8629-8636, 1995
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Activation of Natural Killer Cell Migration by Leukocyte Integrin-binding Peptide from Intracellular Adhesion Molecule-2 (ICAM-2)

Kristina Somersalo , Olli Carpén , Eero Saksela , Carl G. Gahmberg , Pekka Nortamo , Tuomo Timonen

Intracellular adhesion molecule-2 (ICAM-2), one of the ligands of CD11a/CD18 (LFA-1), is mainly expressed on endothelial and hematopoietic cells. The biological significance of ICAM-2 has remained unclear. Previous findings have shown that a peptide from ICAM-2, spanning residues 21-42 from the first immunoglobulin domain, enhances natural killer (NK) cell cytotoxicity and induces T cell aggregation. We have now studied the effect of the same ICAM-2 peptide on NK cell migration in the Boyden chamber assay. The peptide significantly increased NK cell migration up to 215 ± 21%, as compared to migration of control cells (100%), and the induction was inhibited by anti-CD11a monoclonal antibodies. The ICAM-2 peptide also induced polymerization of F-actin at the leading edge of migratory NK cells. Cross-linking of CD11a/CD18 receptors with anti-CD11a or anti-CD18 monoclonal antibodies and secondary antibodies resulted in receptor recycling, increased migration, and actin polymerization, but led to slight inhibition of cytotoxicity. The ICAM-2 peptide did not induce such a receptor recycling. Phosphotyrosine immunoblotting experiments showed that the ICAM-2 peptide increased the phosphorylation of 150- and 35-kDa proteins. During cross-linking with antibodies, only the 150-kDa protein showed increased phosphorylation. The results show that depending on the type of CD11a/CD18 receptor ligation different kinds of signals are transduced in NK cells. These signals may either trigger only locomotion, or both locomotion and cytotoxicity. Based on these findings, a major function for ICAM-2 on endothelium may be triggering of migration of adhering leukocytes.




Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
D. F. Barber, M. Faure, and E. O. Long
LFA-1 Contributes an Early Signal for NK Cell Cytotoxicity
J. Immunol., September 15, 2004; 173(6): 3653 - 3659.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
O. D. Perez, D. Mitchell, G. C. Jager, and G. P. Nolan
LFA-1 signaling through p44/42 is coupled to perforin degranulation in CD56+CD8+ natural killer cells
Blood, August 15, 2004; 104(4): 1083 - 1093.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Tanaka, M. Yashiro, T. Sunami, Y. Sakate, K. Kosaka, and K. Hirakawa
ICAM-2 Gene Therapy for Peritoneal Dissemination of Scirrhous Gastric Carcinoma
Clin. Cancer Res., July 15, 2004; 10(14): 4885 - 4892.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
S. P. McDonough and P. F. Moore
Clinical, Hematologic, and Immunophenotypic Characterization of Canine Large Granular Lymphocytosis
Vet. Pathol., November 1, 2000; 37(6): 637 - 646.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Kotovuori, T. Pessa-Morikawa, P. Kotovuori, P. Nortamo, and C. G. Gahmberg
ICAM-2 and a Peptide from Its Binding Domain Are Efficient Activators of Leukocyte Adhesion and Integrin Affinity
J. Immunol., June 1, 1999; 162(11): 6613 - 6620.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J.-i. Masuyama, T. Yoshio, K. Suzuki, S. Kitagawa, M. Iwamoto, T. Kamimura, D. Hirata, A. Takeda, S. Kano, and S. Minota
Characterization of the 4C8 Antigen Involved in Transendothelial Migration of CD26hi T Cells after Tight Adhesion to Human Umbilical Vein Endothelial Cell Monolayers
J. Exp. Med., March 15, 1999; 189(6): 979 - 990.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement